Indications and uses
Use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with Eczema & Psoriasis.
Use on affected areas for relief of itching, irritation, redness, flaking and scaling associated with Eczema & Psoriasis.
Apply to affected skin 2-3 times daily Smooth in gently The smallest effective dose should be used Patch test recommended on sensitive skin For best results use together with FLEXITOL NATURALS Eczema & Psoriasis Wash.
Store between 50°- 86°F in a dry place
Drug Facts
Water, Cetearyl Alcohol, Paraffin, Zinc Oxide, Paraffin Oil, Lavender Oil, Ceteareth-20, Licorice (Glycyrrhiza Glabra) Extract, Avocado Oil, Chamomile Oil, Diazolidinyl Urea, Phenoxyethanol, Evening Primrose Oil, Tocopheryl Acetate, Aloe Vera Gel
Call Toll Free 1-866-478-3338
usainfo@flexitol.com
www.flexitol.com
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43251-2231-1 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c84b-f6ea-e053-dbdaa90aa703 | Flexitol NATURALS ® ECZEMA & PSORIASIS CREAM |
| 43251-2231-2 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c84b-f6ea-e053-dbdaa90aa703 | Flexitol NATURALS ® ECZEMA & PSORIASIS CREAM |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43251-2231-1 | Flexitol Naturals Eczema and Psoriasis | 1 in 1 CARTON | CREAM | 1 | 2 | |
| 43251-2231-1 | Flexitol Naturals Eczema and Psoriasis | 56 g in 1 TUBE | CREAM | 56 | 2 | |
| 43251-2231-2 | Flexitol Naturals Eczema and Psoriasis | 1 g in 1 PACKET | CREAM | 1 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43251-2231 | FLEXITOL NATURALS ECZEMA AND PSORIASIS (SODIUM BORATE, GRAPHITE, POTASSIUM SULFATE, AND SODIUM CHLORIDE) CREAM [LACORIUM HEALTH INTERNATIONAL PTY LTD] | 2 | Legacy NDC, 3 package rows | 20120124_1cc64c25-d55e-458d-a8c0-77e2997c0369.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Graphite | ACTIVE INGREDIENT | 4QQN74LH4O | 2 | |
| Potassium Sulfate | ACTIVE INGREDIENT | 1K573LC5TV | 2 | |
| Sodium Borate | ACTIVE INGREDIENT | 91MBZ8H3QO | 2 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| Graphite | ACTIVE MOIETY | 4QQN74LH4O | 2 | |
| Potassium Cation | ACTIVE MOIETY | 295O53K152 | 2 | |
| Sodium Cation | ACTIVE MOIETY | LYR4M0NH37 | 2 | |
| Avocado Oil | INACTIVE INGREDIENT | 6VNO72PFC1 | 2 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 2 | |
| Cetearyl Glucoside | INACTIVE INGREDIENT | 09FUA47KNA | 2 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 2 | |
| Chamaemelum Nobile Flower Oil | INACTIVE INGREDIENT | UB27587839 | 2 | |
| Cocoa Butter | INACTIVE INGREDIENT | 512OYT1CRR | 2 | |
| Evening Primrose Oil | INACTIVE INGREDIENT | 3Q9L08K71N | 2 | |
| Glycyrrhiza Glabra | INACTIVE INGREDIENT | 2788Z9758H | 2 | |
| Lavandula Angustifolia Flower | INACTIVE INGREDIENT | 19AH1RAF4M | 2 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 2 | |
| Shea Butter | INACTIVE INGREDIENT | K49155WL9Y | 2 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 | |
| Zinc Oxide | INACTIVE INGREDIENT | SOI2LOH54Z | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 43251-2231 | 43251-2231-1, 43251-2231-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SUPPOSITORY / RECTAL | 375 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / SUBLINGUAL | 0.16 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED / ORAL | 5 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION/ DROPS / OPHTHALMIC | 0.2 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, DELAYED RELEASE / ORAL | 0.03 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION / ORAL | 80 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| Cocoa Butter | COCOA BUTTER | 512OYT1CRR | SUPPOSITORY / RECTAL | 2280 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, COATED / ORAL | 1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CONCENTRATE / ORAL | 1 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SOLUTION / RESPIRATORY (INHALATION) | 3.11 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | INJECTION / SUBCUTANEOUS | 0.02 %w/v | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SYRUP / ORAL | 80 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SUSPENSION / ORAL | 40 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | INJECTION, SUSPENSION / SUBCUTANEOUS | NA | ||
| Shea Butter | SHEA BUTTER | K49155WL9Y | LOTION / TOPICAL | 2340 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | GEL / TOPICAL | 2 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | LOTION / TOPICAL | 4 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | EMULSION / OPHTHALMIC | 1 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | SOLUTION / INTRAVENOUS | 3.11 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| Zinc Oxide | ZINC OXIDE | SOI2LOH54Z | LOTION / TOPICAL | 16 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f268a8f9-84db-453a-8e1f-1b8c692724d2 | 1cc64c25-d55e-458d-a8c0-77e2997c0369 | 2012-01-20 | Warnings | f268a8f9-84db-453a-8e1f-1b8c692724d2 1cc64c25-d55e-458d-a8c0-77e2997c0369 |
Adverse event summaries are temporarily unavailable. Other product information remains available.